BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 30
• 31

• BioMidwest

  Hill-Rom to Present at the 37th Annual J.P. Morgan Healthcare Conference

  Hill-Rom Holdings, Inc. will present at the 37th Annual J.P. Morgan Healthcare Conference on Tuesday, January 8, 2019, in San Francisco. John Groetelaars, Hill-Rom’s president and chief executive officer, is scheduled to present at 1:30 p.m. Pacific Time.

  December 5, 2018

   · 

  1 min read
• Shield Therapeutics notes UK launch of Feraccru® by Norgine

  Shield Therapeutics plc (LSE:STX), a commercial stage, pharmaceutical company delivering innovative specialty pharmaceuticals to address patients’ unmet medical needs, is pleased to note the announcement today by Norgine that they have launchedFeraccru® in the UK.

  December 5, 2018

   · 

  3 min read
• BioForest

  New Genomic Technology Advances Fight Against Global Health Threat of Antibiotic Resistance

  Phase Genomics, the leader in proximity-ligation genome assembly technology released an antimicrobial resistance (AMR) study led by researchers from the University of Idaho utilizing Phase Genomics’ proprietary metagenome assembly technology.

  December 5, 2018

   · 

  2 min read
• Drug Development

  Daiichi Sankyo Presents Updated Phase 1 Data for U3-1402 in Patients with HER3-Expressing Metastatic Breast Cancer at 2018 San Antonio Breast Cancer Symposium (SABCS)

  Updated efficacy and safety results presented from ongoing phase 1/2 study with U3-1402, an investigational and potential first-in-class HER3-targeting antibody drug conjugate (ADC), in patients with heavily pretreated HER3-positive metastatic breast cancer

  December 5, 2018

   · 

  7 min read
• Rafael Holdings to Present at 2018 LD Micro Investor Conference

  Rafael Holdings, Inc. today announced that its Chief Financial Officer, David Polinsky, will present an overview of the Company’s business and strategy at the 11th annual LD Micro Main Event on Thursday, December 6th at 7:30 AM PST / 10:30 AM EST.

  December 5, 2018

   · 

  1 min read